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Healthy liver sinusoidal endothelial cells (LSECs) maintain liver homeostasis, while
LSEC dysfunction was suggested to coincide with defenestration. Here, we have
revisited the relationship between LSEC pro-inflammatory response, defenestration,
and impairment of LSEC bioenergetics in non-alcoholic fatty liver disease (NAFLD) in
mice. We characterized inflammatory response, morphology as well as bioenergetics
of LSECs in early and late phases of high fat diet (HFD)-induced NAFLD. LSEC
phenotype was evaluated at early (2–8 week) and late (15–20 week) stages of NAFLD
progression induced by HFD in male C57Bl/6 mice. NAFLD progression was monitored
by insulin resistance, liver steatosis and obesity. LSEC phenotype was determined in
isolated, primary LSECs by immunocytochemistry, mRNA gene expression (qRT-PCR),
secreted prostanoids (LC/MS/MS) and bioenergetics (Seahorse FX Analyzer). LSEC
morphology was examined using SEM and AFM techniques. Early phase of NAFLD,
characterized by significant liver steatosis and prominent insulin resistance, was related
with LSEC pro-inflammatory phenotype as evidenced by elevated ICAM-1, E-selectin
and PECAM-1 expression. Transiently impaired mitochondrial phosphorylation in LSECs
was compensated by increased glycolysis. Late stage of NAFLD was featured
by prominent activation of pro-inflammatory LSEC phenotype (ICAM-1, E-selectin,
PECAM-1 expression, increased COX-2, IL-6, and NOX-2 mRNA expression), activation
of pro-inflammatory prostaglandins release (PGE2 and PGF2α) and preserved LSEC
bioenergetics. Neither in the early nor in the late phase of NAFLD, were LSEC fenestrae
compromised. In the early and late phases of NAFLD, despite metabolic and pro-
inflammatory burden linked to HFD, LSEC fenestrae and bioenergetics are functionally
preserved. These results suggest prominent adaptive capacity of LSECs that might
mitigate NAFLD progression.
Keywords: LSEC metabolism, LSEC inflammation, LSEC porosity, non-alcoholic fatty liver disease, liver steatosis
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INTRODUCTION
The LSECs, belonging to the group of liver non-parenchymal
cells, comprise approximately 20% of the total number of liver
cells (Sørensen et al., 2015). LSECs are characterized by a unique
morphology and specialized function which differentiate them
from other endothelial cells in the body (Aird, 2007). Moreover,
the unique LSEC ability to eliminate a variety of macromolecules
from the blood circulation by receptor-mediated endocytosis
makes LSECs highly specialized scavenger cells (Sørensen et al.,
2012). Although the scavenger activity of LSECs has been
widely investigated, the potential significance of their barrier
function is still neglected and knowledge about the role of LSEC
defenestration in liver diseases is still limited.
In healthy liver, the presence of LSEC fenestrae and
lack of basement membrane do not represent a barrier
for macromolecule transport in the same sense as vascular
endothelial cells in other organs. Still, because of the active
regulation of the passage of a wide range of solutes and
macromolecules between blood and hepatocytes, LSECs present
a ‘dynamic, functional barrier’ protecting the liver parenchyma
(Fraser et al., 1995; Sørensen et al., 2015). Several studies have
stressed the importance of LSEC defenestration as the main
characteristic or even early event in the development of liver
pathology (Poisson et al., 2017). The lack of LSEC fenestrae
directly contributes to intrahepatic resistance and hepatocellular
damage (Francque et al., 2012). Furthermore, maintaining
LSECs’ fenestrae-dependent blood filtration is thought to be
particularly important for the hepatic metabolism of lipids
(Fraser et al., 1995). Defenestration has been shown to impair
the hepatic uptake of various lipoproteins that may lead to
severe hyperlipoproteinemia and liver steatosis (Clark et al., 1988;
Herrnberger et al., 2014). Le Couteur et al. (2002) have suggested
that there is a link between the defenestration commonly
associated with aging and impaired clearance of cholesterol
rich chylomicron remnants in elderly people, increasing the
risk for development of lipid abnormalities and atherosclerosis.
Accordingly, LSEC defenestration may represent an important
pathogenic mechanism contributing to NAFLD development.
This disease, ranging from simple steatosis, through steatosis
with inflammation and fibrosis (NASH) may result in cirrhosis
or hepatocellular carcinoma. Moreover, NAFLD (affecting more
than 25% of the global population) is closely related with obesity
Abbreviations: 2DG, 2-deoxy-D-glucose; AFM, atomic force microscopy; Akt,
protein kinase B; ALT, alanine aminotransferase; AST, aspartate aminotransferase;
AUC, area under the curve; CDAA, choline-deficient, L-amino acid-defined
diet; CHOL, total cholesterol; COX-2, cyclooxygenase-2; ECAR, extracellular
acidification rate; eNOS, endothelial nitric oxide synthase; FACRs, fenestrae-
associated cytoskeleton rings; GTT, glucose tolerance test; HDL, high-density
lipoprotein cholesterol; HFD, high fat diet; HSCs, hepatic stellate cells; ICAM-
1, intercellular adhesion molecule 1; IL-6, interleukin 6; LDL, low-density
lipoprotein cholesterol; LSECs, liver sinusoidal endothelial cells; MCPIP1,
monocyte chemotactic protein-1-induced protein-1; NAFLD, non-alcoholic fatty
liver disease; NASH, non-alcoholic steatohepatitis; NO, nitric oxide; NOX-2,
NADPH oxidase 2; OCR, oxygen consumption rate; ORO, Oil Red O; PECAM-
1, platelet endothelial cell adhesion molecule-1; PGD2, prostaglandin D2; PGE2,
prostaglandin E2; PGF2α, prostaglandin F2α; PGI2, prostacyclin; PSR, Picro Sirius
Red; SEM, scanning electron microscopy; TGs, triglycerides; TXA2, thromboxane
A2; TXB2, thromboxane B2.
(51%), hyperlipidemia (69%), insulin resistance (22.5%), and
hypertension (39%) (Younossi et al., 2016).
A number of studies have suggested the involvement
of LSEC dysfunction in NAFLD (Maslak et al., 2015a,b).
Functional studies showed that the impairment in NO-dependent
vasodilation response to insulin in the isolated liver was present
as soon as after 3 days of HFD in rats, implying that LSEC
dysfunction may be one of the earliest features of NAFLD
(Pasarín et al., 2011). Moreover, NAFLD-related impairment of
LSEC function was linked to increased hepatic portal perfusion
pressure and downregulation of the Akt/eNOS pathway that
preceded liver inflammation and fibrosis (Pasarín et al., 2012).
On the other hand, liver steatosis may induce adaptive, anti-
inflammatory LSEC response, as evidenced by a decrease in
pro-inflammatory chemokine production in LSECs as opposed
to hepatocytes producing more pro-inflammatory chemokines in
response to free fatty acids (McMahan et al., 2016).
Liver sinusoidal endothelial cell fenestrae formation and their
regulation is a dynamic process that is closely associated with the
LSEC cytoskeleton (Wisse, 1972; Steffan et al., 1987; Braet et al.,
1995; Braet et al., 1996b; Zapotoczny et al., 2018). However, the
exact mechanism responsible for LSEC defenestration remains
to be elucidated (Venkatraman and Tucker-Kellogg, 2013;
Herrnberger et al., 2014; Hunt et al., 2018). Interestingly, reports
suggest that regulation of fenestrae size directly depends on
LSEC bioenergetic status (i.e., ATP depletion leads to LSEC
defenestration) (Braet et al., 2003; Zapotoczny et al., 2017c).
Given the fact that it is not entirely clear whether LSEC
dysfunction always coincides with defenestration, we revisited
the relationship between LSEC pro-inflammatory response,
defenestration and impairment of LSEC bioenergetics in NAFLD
in mice. For that purpose, we simultaneously characterized
inflammatory response, morphology as well as bioenergetics of
LSECs in early and late phases of HFD-induced NAFLD.
MATERIALS AND METHODS
Animals and Experimental Design
In the experiments, 6-week old male C57Bl/6 mice were fed
control (AIN-93G) or HFD (60 kcal% of fat) (Research Diets,
United States) for 2, 4, and 8 weeks (n = 3–4/group/each
experimental time-point) reflecting the early stage of NAFLD
and 15 and 20 weeks (n = 6–8/group/each experimental time-
point) reflecting the late phase of the disease. Mice dedicated
for assessment of in vivo NAFLD progression and LSEC
bioenergetics were obtained respectively from animal research
facilities of the Nofer Institute of Occupational Medicine in
Łodz (Poland) for early stage of NAFLD and from the Medical
University of Bialystok (Poland) for the late phase of NAFLD.
In turn, mice for assessment of LSEC structure and molecular
biology research were purchased from animal research facilities
of the Medical University of Bialystok (Poland). The number of
mice dedicated for LSEC isolation was at least three animals per
group. Animals were housed in colony cages in a temperature-
controlled environment (22–25◦C) with a 12 h light/dark cycle.
Mice had free access to food and water. At the end of the
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experiment, the mice were weighted to obtain final body mass and
anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg)
administered intraperitoneally.
All procedures involving animals were conducted according
to the Guidelines for Animal Care and Treatment of the
European Union and were approved by the I Local Animal
Ethics Commission at Jagiellonian University in Kraków, Poland
(Permit No. 292/2015).
Blood Biochemistry
At the end of each experimental time-point, blood was collected
under fasting conditions (4 h) from the left ventricle of the
mice heart and placed into plastic tubes containing 20 I.U./ml
heparin. Plasma was obtained by blood centrifugation (1,000× g
for 10 min) and used for the following measurements: CHOL,
HDL, LDL, TGs, ALT, and AST. These parameters were measured
by the enzymatic photometric method using an automatic
biochemical analyzer Pentra 400 (Horiba, Japan) according to the
manufacturer’s instructions.
Histological Evaluation of Liver Steatosis
Fragments of liver tissue were fixed in 4% buffered formalin.
One fragment was prepared according to the standard paraffin
method and stained with hematoxylin and eosin (HE) for general
histology and immune cell infiltration and PSR for collagen
deposition (Kus et al., 2018), while the second fragment was
immersed in a 30% sucrose solution overnight for cryoprotection
and afterward frozen in Tissue-Tek R©OCT (optimum cutting
temperature) medium at −80◦C. Frozen sections were cut into
7-µm thick sections, stained with ORO for fat deposition (Kus
et al., 2018) and photographed under × 100 magnification.
At least six images of each section were randomly obtained.
The images were subsequently analyzed in terms of steatosis by
using the Columbus Image Data Storage and Analysis System
(Perkin Elmer, United States) with an algorithm adapted for ORO
stained sections.
Assessment of Insulin Resistance
Fasting plasma glucose concentration was measured by
the enzymatic photometric method using an automatic
biochemical analyzer Pentra 400 (Horiba, Japan) according to
the manufacturer’s instructions. A GTT was performed at the end
of each experimental time-point in fasting (4 h) mice injected
intraperitoneally with glucose solution (2 g/kg of body weight).
Blood was collected from the tail veins before (0 min) and at
15, 30, 45, 60, and 120 min after glucose administration. Blood
glucose concentrations were measured using a glucometer (Accu-
Check, Roche Diagnostic, France). For assessing the GTT, the
AUC of blood glucose concentration was calculated geometrically
by applying the trapezoidal method (Venn and Green, 2007).
Protocol of LSECs Isolation
The primary LSECs were isolated from C57Bl/6 mice fed for 2–
20 weeks HFD according to a protocol presented by Smedsrød
and Pertoft (1985) with modification (Kochan et al., 2017;
Zapotoczny et al., 2018). Briefly, liver was initially perfused
with perfusion buffer (37◦C) in order to purify it from the
blood and then with buffered collagenase (Liberase TM (Roche)).
Parenchymal cells (hepatocytes) were removed using low-
speed centrifugation at 50 × g. The LSECs were isolated by
gradient density sedimentation of resting non-parenchymal cells
on 25–50% Percoll and purified using LSEC-specific CD146-
based isolation on magnetic MicroBeads (MACS, MiltenyiBiotec,
Germany). The LSEC fraction yielded approximately 2–8 × 106
LSECs per liver with a purity of >95% cells, as determined by
SEM and AFM microscopy and high acetylated LDL endocytosis.
Isolated LSECs were incubated overnight in EBM-2 Basal
Medium (Lonza) supplemented with 1% Antibiotic Antimycotic
Solution for Cell Culture (Sigma-Aldrich), under 37◦C and 5%
CO2 conditions to spread out, unless otherwise stated. Isolated
LSEC were used for experiments within 24 h from the isolation.
LSEC Immunocytochemistry
Isolated LSECs after overnight incubation were washed with
PBS, fixed with 4% formaline solution (10 min), slightly
permeabilized using 0.1% Triton-X (5 min), then preincubated
for 30 min with blocking buffer containing 5% normal goat
serum (Jackson Immuno) and 2% dry milk. Immunofluorescent
staining was performed for 1 h using rat anti-E selectin Ig
(Invitrogen), rabbit anti-CD31 Ig, rat anti-ICAM1 Ig (Abcam)
or mouse anti-eNOS Ig (Sigma-Aldrich), followed by goat-
anti-rabbit, goat-anti-rat or goat-anti-mouse Cy3-conjugated
secondary antibodies (Jackson Immuno) applied for 30 min.
Cells stained with mouse antibodies were previously incubated
with MOM blocking reagent (Vector) to reduce unspecific
binding. Hoechst 33258 (Sigma-Aldrich) was used for nuclei
counterstaining. Serial cell images were taken using an Olympus
ScanR automated fluorescence microscope (Olympus), stored as
integrated datasheets and analyzed automatically by Columbus
software (Perkin Elmer).
qRT-PCR of Isolated LSECs
Total RNA was isolated from LSECs after overnight culture at
37◦C in an atmosphere containing 5% O2 using a modified
guanidinium isothiocyanate method (Chomczynski and Sacchi,
2006). Briefly, cells were lysed in fenozol (A&A Biotechnology),
and after addition of chloroform, the aqueous phase containing
RNA was collected into new eppendorf tubes. Next, RNA was
precipitated, centrifuged, washed in ethanol and finally dissolved
in nuclease-free water. RNA concentration was measured with an
ND-1000 spectrophotometer (Thermo Fisher Scientific). Reverse
transcription was performed using 0.5 µg of total RNA with
random hexamers and M-MLV reverse transcriptase (Promega)
according to the vendor’s instructions. Gene expression was
measured by real-time PCR (Eco, Illumina) with a SybrGreen
master mix (A&A Biotechnology) according to the protocol:
95◦C for 5 min followed by 40 cycles of melting at 95◦C – 20 s,
annealing at 58–62◦C – 20 s, elongation at 72◦C – 30 s. The
relative quantification of gene expression was calculated with the
2−11Ct method. Primer sequences, annealing temperatures and
length of PCR products are listed in Table 1.
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Quantification of Production of
Prostaglandins by LSECs
Prostaglandin production was assessed in EBM-2 (Lonza)
medium from LSECs after overnight incubation at 37◦C
in an atmosphere containing 5% O2 according method
partially described by Kij et al. (2016). In details, samples
were spiked with deuterated internal standards mixture
(PGE2-d4, PGD2-d4, PGF2α-d4, 6-keto-PGF1α-d4) and
purified via liquid-liquid extraction technique using ethyl
acetate acidified with 0.13% AA (v/v). After shaking, samples
were centrifuged, and the organic layer was collected and
evaporated to dryness under nitrogen stream at 37◦C. The
dry residues were reconstituted in EtOH and samples were
injected into the UPLC-MS system. The quantification of
selected prostaglandins (PGE2, PGD2, PGF2α, 6-keto-PGF1α)
was performed using a UFLC Nexera liquid chromatograph
system (Shimadzu, Kyoto, Japan) coupled to a QTrap 5500
triple quadrupole mass spectrometer (Sciex, Framingham, MA,
United States). Samples were injected onto an Acquity UPLC
BEH C18 (3.0 mm × 100 mm, 1.7 µm, Waters, Milford, MA,
United States) analytical column and analytes were separated
under gradient elution applying 0.1% formic acid in acetonitrile
(A) and 0.1% formic acid in water (v/v) (B) as mobile phases.
The detection of eluted prostaglandins was carried out using
negative ion electrospray ionization mass spectrometry in the
multiple reaction monitoring mode (MRM) for all analytes
and their deuterated internal standards. The ion transitions
selected for quantification of studied prostaglandins and used
internal standards were as follows: PGE2 (351.1→315.1),
PGD2 (351.1→315.1), PGF2α (353.1→193.0), 6-keto-PGF1α
(369.2→163.0) and PGE2-d4 (355.5→275.2), PGD2-d4
(355.5→275.2), PGF2α-d4 (357.4→197.3), 6-keto-PGF1α-d4
(373.3→167.1).
Data acquisition was performed under optimized conditions:
spray voltage: −4500 V, source temperature: 500◦C, curtain gas:
25 psi, ion source gas 1: 40 psi, ion source gas 2: 50 psi.
Assessment of Thromboxane B2 and
Nitrite Production Using Isolated
Perfused Liver Set Up
A monovascular perfusion technique of liver perfusion was used
in this study as described previously (Kus et al., 2017). The portal
perfusion was performed in a recirculation manner with Krebs–
Hanseleit buffer (118.0 mM NaCl, 2.52 mM CaCl2, 1.16 mM
MgSO4, 24.88 mM NaHCO3, 1.18 mM KH2PO4, 4.7 mM KCl,
10.0 M glucose, 2.0 mM pyruvic acid, and 0.5 mM EDTA)
at a constant flow rate of 2.7 ml/min/g of liver. Buffer was
continuously heated to 37◦C and oxygenated with 95% O2 and
5% CO2. To evaluate organ viability, activity of liver enzymes
(ALT, AST, LDH) was measured in the output eﬄuent using
the Pentra 400 automatic biochemical analyzer (Horiba, Kyoto,
Japan), according to the manufacturer’s instructions.
The concentration of nitrite was measured in liver perfusate
after a stabilization period. Nitrite concentration was analyzed
using a NOx analyzing system, ENO-20 (Eicom, Kyoto,
Japan) based on a liquid chromatography method with post-
column derivatization with Griess reagent as it was described
by Kus et al. (2015).
The thromboxane B2 (TXB2) concentration was measured
in liver perfusate obtained at 0 min (after stabilization period)
and after 30 min of perfusion of isolated liver. The quantitative
determination of TXB2 (a stable derivative of TXA2) in
those samples was performed with a commercially available
ELISA kit (Enzo Life Sciences, United States) according to
manufacturer’s instruction. Data are presented as 30 min liver
TXB2 release (1TXB2) calculated from differences between
TXB2 concentrations at time 30 min and 0 min (1TXB2 =
t30 min conc.− t0 minconc.).
Assessment of LSEC Fenestrae Using
SEM
Isolated LSECs plated on coverslips were incubated overnight in
EBM-2 medium (Lonza) at 37◦C in an atmosphere containing 5%
CO2. Afterward, LSECs were fixed in 2% glutaraldehyde/0.1 M
sodium cacodylate/0.1 M sucrose overnight and dehydrated in
ethanol gradients of 35 and 70% in 0.1 M sucrose, followed
by 95 and 100% ethanol (15 min each). Dried samples were
coated with gold using spatter Coater (Jeol JFC-1200 Fine
Coater). Cells were imaged with a SCM (Jeol JSM – 7600)
at a voltage of 5.0 kV. Microphotograph analysis revealed
that among isolated LSECs, the number of cells with shrunk
cytoplasm was increased in the HFD group; therefore, for
further morphometric analysis, only LSECs with preserved
morphology were concerned. The LSEC fenestra measurements
were performed from SEM microphotographs taken under a
magnification of x5,000 (to characterize the cell morphology and
determine the cell area without nuclei), x7,500 (to estimate the
number fenestrae and their total area in the cell) and x15,000 (to
define consecutive areas in which the diameter of each fenestra
was then measured). All measurements were made using the
CellSense morphometric program (Olympus).
Assessment of LSEC Fenestrae Using
AFM Imaging
Freshly isolated LSECs were seeded onto uncoated glass
coverslips in EGM-2 medium (Lonza) and incubated overnight
at 37◦C in an atmosphere containing 5% CO2. Afterward,
LSECs were fixed with 1% glutaraldehyde for 2 min to
determine the porosity and fenestra diameter distribution.
All measurements were performed within 1 week. The
AFM imaging was conducted in phosphate−buffered
saline with Mg2+ and Ca2+ (PBS) using Nanowizard 3 JPK
Instruments in a commercial liquid cell with the temperature
controller (25◦C).
Porosity and fenestrae diameter distributions were
determined according to a procedure described previously
(Zapotoczny et al., 2017a,b,c). Briefly, for imaging we used
a novel fast AFM imaging mode, so-called Quantitative
Imaging (QI, JPK Instruments), in which force versus distance
curves are acquired point-by-point over a selected scanning
area in times of milliseconds each and translated into a
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FIGURE 1 | Fasting glucose concentration and GTT with calculated AUC of the GTT (A). Representative images of liver steatosis (ORO staining) (B), immune cells
infiltration (HE staining) (C) and fibrosis (Picro Sirius Red staining) (D) and summary results of liver steatosis (B), performed in C57Bl/6 mice at early and late stage of
NAFLD progression. Values are means ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from HFD feeding time-matched AIN-93G group values.
AIN-93G, AIN-93G diet fed group; HFD, high fat diet fed group.
topographical image. The loading forces were adjusted to
a particular image and probe and were within the range of
200–600 pN. Collected data were processed with JPK Data
Processing Software and Fiji ImageJ software (NIH, Bethesda,
MD, United States).
Fenestra diameter distribution was determined by performing
high-magnification images of single sieve plates. Scanning
areas were in the range of 10s of square micrometers,
but point-to-point imaging resolution was always set below
15 nm. Cantilevers with sharpened tips (2–12 nm) were
used for such measurements. We measured the diameter
of fenestrae which were open (i.e., we could always reach
the glass slide in the interior of fenestrae). Images from
different LSECs isolated from at least two mice (control and
HFD-fed mice), were used to create histograms of fenestra
size distribution.
Porosity was calculated using large QI AFM images of a
few cells selected from LSECs organized on a coverslip in a
monolayer or in groups of five or more. Image sizes and point-
to-point resolutions were as follows: 40 × 40 to 50 × 50 µm
and 512 × 512 to 800 × 800 lines. Because of limited point-to-
point resolution of such scans (62–78 nm per pixel), we were not
able to properly estimate fenestrae size and area directly from
the large images. Therefore, in order to calculate the porosity
of LSECs, at first, we counted the number of fenestrae in each
large image manually, using a Cell Counter under Fiji software,
and then using the fenestrae size distribution and assuming that
fenestrae are circular, we calculated the area which is occupied
by the fenestrae (for details see Zapotoczny et al., 2017b). We
excluded areas of cell nuclei and gaps larger than 400 nm
in diameter. While doing so, we ensured that calculation of
porosity is not affected by the location of the selected area.
Consequently, we determined the porosity as a ratio of the
area occupied by the fenestrae to the total area where fenestrae
could be formed. Every point on the graph from Figure 6,
therefore, represents a single AFM image, which illustrated
2–3 cells.
Assessment of LSEC Bioenergetics
Metabolic analyses were performed using an Agilent Seahorse
XFe96 Analyzer (Seahorse Bioscience, North Billerica), which
enables real-time, simultaneous measurement of OCR (reflecting
mitochondrial respiration) and ECAR (reflecting glycolysis) as
described by Kaczara et al. (2015) with some modifications.
Briefly, LSECs were seeded into Seahorse XFe96 plates 18 h
prior to the experiment at a density of 70,000 cells per
well, which was selected as optimal based upon a preliminary
experiment and incubated overnight under 37◦C and 5% CO2
conditions. On the day of the experiment, the cells were washed
twice and incubated for 1 h prior to the beginning of the
assay at 37◦C in the absence of CO2 within bicarbonate-
free low buffered XF assay media supplemented with 1 g/l of
glucose, 2 mM glutamine, and 1 mM pyruvate (pH = 7.4)
for the Agilent Seahorse XF Mito Stress Test or with 2 mM
glutamine (glucose-free, pH = 7.4) for the Agilent Seahorse
XF Glycolysis Stress Test. The media were prepared freshly
on the day of the experiment. In the XF Cell Mito Stress
Test, mitochondrial respiration was assessed overtime, followed
by addition of oligomycin (1 µg/ml), FCCP (2 µM) and
a mixture of rotenone (1 µM) and antimycin A (1 µM),
respectively (concentrations of mitochondrial modulators were
optimized based upon a preliminary experiment), allowing for
determination of basal respiration, ATP turnover, proton leak
and maximal respiratory capacity. In the XF Glycolysis Stress
Test, glycolysis was assessed overtime followed by addition of
glucose (10 mM), oligomycin (1 µg/ml) and 2DG (50 mM)
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TABLE 1 | Sequences of primers used in qRT-PCR analysis of gene expression.
Gene NCBI accession no. Forward 5′–3′ Reverse 5′–3′ TA Product (bp)
Ptgs1 NM_008969.4 ATTGCACATCCATCCACTCCC AGTTGTCGAGGCCAAAGCG 62 196
Ptgs2 NM_011198.4 CTTTGCCCAGCACTTCACCC GGGGATACACCTCTCCACCAA 64 191
Cybb NM_007807.5 AAGTTCGCTGGAAACCCTCC GCCAAAACCGAACCAACCTC 62 88
Il6 NM_031168.2 ACTTCACAAGTCGGAGGCTT GGTACTCCAGAAGACCAGAGG 64 220
Zc3h12a NM_153159.2 CAGCCTCGACCAGATGTGCC CAGCCGCTCCTCGATGAAGC 62 237
Ef2 NM_001961 GACATCACCAAGGGTGTGCAG TTCAGCACACTGGCATAGAGGC 62 214
TA, annealing temperature.
respectively, allowing for determination of basal glycolysis and
maximal glycolytic capacity.
Statistical Analysis
Results are presented as mean ± SD. The assessment of
normality and homogeneity of variances was performed using
the Shapiro–Wilk and Levene’s tests, respectively. Based on the
results, the non-parametric Mann–Whitney U-test or parametric
Student’s t-test was used to assess the statistical significance
of ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 between time-
matched experimental groups. The results were analyzed using
STATISTICA 12.0.
RESULTS
NAFLD Development in HFD-Fed Mice
Early and late phases of NAFLD at 2 and 20 weeks of HFD feeding
is characterized in Figure 1 and Table 2.
Early phase of NAFLD in HFD-fed mice was not associated
with changes in body or liver weight (Table 2). No differences
in lipid profile (CHOL, LDL, HDL, TG) or ALT were observed
(Table 2). However, the GTT (Figure 1A) indicated development
of insulin resistance, despite a lack of difference in plasma fasting
glucose (Figure 1A). Histological examination of liver samples
showed mild, microvesicular hepatic steatosis without immune
cell infiltration or fibrosis (Figures 1B–D).
In the late phase of NAFLD, HFD-fed mice gained significantly
more weight and had increased liver weight (Table 2). Plasma
concentrations of CHOL, LDL and liver enzymes (AST, ALT),
but not HDL and TG, were also significantly elevated (Table 2).
Fasting plasma glucose concentration and glucose plasma
response during the GTT were significantly increased, indicating
severe hyperglycemia and insulin resistance in mice fed HFD for
20 weeks (Figure 1A). Histological analysis displayed prominent
macrovesicular liver steatosis without inflammation or fibrosis
(Figures 1B–D).
Pro-inflammatory Phenotype in LSECs in
Early and Late Phases of NAFLD
In the early stage of NAFLD, LSECs displayed increased
PECAM-1, E-selectin and ICAM-1 expression (Figures 2B–D)
without changes in mRNA expression of pro-inflammatory
genes (Figures 3A–D) or prostanoid production (Figures 4A–
D). In turn, in the late phase of NAFLD, there was a
prominent induction of LSECs’ pro-inflammatory phenotype
characterized by increased PECAM-1, E-selectin, and ICAM-1
expression (Figures 2B–D) and significantly increased mRNA
expression of COX-2, IL-6, NOX-2 (Figures 3B–D) and
production of pro-inflammatory prostanoids such as PGE2 and
PGF2a (Figures 4A,B). Interestingly, LSECs’ pro-inflammatory
activation was compensated by MCPIP1 mRNA overexpression
(Figure 3E) and increased secretion of anti-inflammatory PGI2
(measured as 6-keto-PGF1α) and PGD2 (Figures 4C,D) in the
late, but not in the early stage of NAFLD. During early and late
phase NAFLD progression, no significant changes in nitrite and
TXB2 production examined ex vivo in isolated perfused mice
liver were observed (data not shown). In early and late phases
of NAFLD, LSEC expression of eNOS (Figure 2A) or COX-1
(Figure 3A) did not change.
LSEC Fenestrae in Early and Late
Phases of NAFLD
In order to determine changes in LSECs morphology, SEM and
AFM techniques were used. SEM analysis revealed that LSEC
fenestrae were preserved at all stages of NAFLD progression
(Figure 5A). In detail, analysis of the frequency distribution of
LSEC fenestra diameters showed larger diameter of fenestrae
in HFD as compared to the AIN-93G group at each stage
of NAFLD progression (Figure 5B). Mean diameter of LSEC
fenestrae was also larger in the HFD group at each experimental
time point (Figure 5C). However, overall LSEC porosity, apart
from 4 weeks, did not differ between experimental groups during
NAFLD progression (Figure 5D). Interestingly, despite the fact
that LSECs porosity was lower in the AIN-93G than the HFD
group at 4 weeks (Figure 5D), in general LSEC fenestrae diameter
stayed preserved in both groups and did not change with disease
progression or animal aging (Figure 5D).
Morphology measurements with AFM were in line with
results obtained by SEM because they confirmed that LSEC
fenestrae were preserved even at the late stage of NAFLD in HFD
mice (Figure 6A). Accordingly, differences in LSEC porosity
between experimental groups at early and late stage of NAFLD
were not found either in SEM or AFM data (Figures 5D, 6D).
Interestingly, in contrast to SEM, AFM measurements showed
practically the same mean fenestrae diameters in HFD and AIN-
93G groups at the early phase of NAFLD. Furthermore, both
techniques identified a significantly increased number of LSECs
with bigger fenestrae (up to 400 nm in diameter) in the HFD
group for the late stage of disease (Figures 6B,C). Importantly,
Frontiers in Physiology | www.frontiersin.org 6 February 2019 | Volume 10 | Article 6
fphys-10-00006 February 9, 2019 Time: 17:29 # 7
Kus et al. LSECs Adaptive Capacity in Liver Steatosis
FIGURE 2 | Represenatative immunofluorescence staining and quantitative analysis of immunofluorescence intensity for eNOS (A), PECAM-1 (B), E-selectin (C),
and ICAM-1 (D) on primary LSECs isolated from C57Bl/6 mice fed AIN-93G and HFD for 2 and 20 weeks. Values are means ± SD. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001 significantly different from HFD feeding time-matched AIN-93G group values. AIN-93G, AIN-93G diet fed group; HFD, high fat diet fed group.
because the AFM technique allows us for observation and
measurements of dynamic fenestrae rearrangements (Braet and
Wisse, 2017; Zapotoczny et al., 2018), we stress that analyzed
fenestrae with diameters up to 400 nm are fully functional and
therefore taken for analysis. Moreover, similarly to SEM results,
the AFM method showed diminished LSEC porosity related with
aging (Figure 6D).
LSEC Bioenergetics in the Early and Late
Stages of NAFLD
Liver sinusoidal endothelial cell bioenergetics were largely
preserved at early as well as in late stages of NAFLD
(Figures 7A,B). Visible in early NAFLD mild impairment
of mitochondrial phosphorylation (decreased ATP production,
impaired maximal mitochondrial respiration and increased
proton leak) (Figure 7A) was compensated by concomitant
increased LSEC basal glycolysis and maximal glycolysis capacity
(Figure 7B). Proton leak tended to increase in the NAFLD group,
but this difference reached significance only at the time point of
4 weeks of HFD.
DISCUSSION
In the present study, we demonstrated that in HFD-induced
NAFLD in mice, featured by prominent insulin resistance,
liver steatosis and obesity, LSECs displayed a pro-inflammatory
TABLE 2 | Body weight, liver weight, and fasting plasma parameters in C57Bl/6 mice fed AIN-93G and HFD for 2 and 20 weeks.
2 weeks 20 weeks
AIN-93G HFD AIN-93G HFD
Body weight [g] 29.35 ± 0.27 32.67 ± 3.99ns 32.19 ± 3.78 51.45 ± 1.64∗
Liver weight [% b.w.] 5.48 ± 0.77 4.91 ± 0.56ns 3.96 ± 0.36 5.47 ± 1.30∗
ALT [U/L] 28.05 ± 4.45 40.03 ± 13.27ns 67.55 ± 37.76 228.98 ± 86.15∗
AST [U/L] 81.66 ± 2.20 64.61 ± 5.61∗ 125.91 ± 14.43 212.37 ± 59.71∗
CHOL [mmol/L] 3.57 ± 0.23 3.83 ± 0.60ns 2.93 ± 0.83 4.92 ± 1.16∗
HDL [mmol/L] 2.00 ± 0.15 2.10 ± 0.40ns 1.61 ± 0.42 1.93 ± 0.32ns
LDL [mmol/L] 0.44 ± 0.13 0.43 ± 0.02ns 0.20 ± 0.09 0.57 ± 0.19∗
TG [mmol/L] 0.99 ± 0.38 0.63 ± 0.15ns 0.46 ± 0.20 0.40 ± 0.13ns
Values are means ± SD (n = 3–8 animals per group). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from HFD feeding time-matched AIN-93G group values.
AIN-93G, AIN-93G diet fed group; HFD, high fat diet fed group; ALT, alanine aminotransferase; AST, aspartate transaminase; CHOL, total cholesterol; HDL, high density
cholesterol; LDL, low density cholesterol; TGs, triglycerides.
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FIGURE 3 | mRNA gene expression of COX-1 (A) and COX-2 (B), IL-6 (C), NOX-2 (D), and MCPIP1 (E) in primary LSEC isolated from C57Bl/6 mice fed AIN-93G
and HFD for 2 and 20 weeks. Values are means ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from HFD feeding time-matched AIN-93G group
values. AIN-93G, AIN-93G diet fed group; HFD, high fat diet fed group; COX-1, cyclooxygenase-1; COX-2, cyclooxygenase-2; IL-6, interleukin 6; NOX-2, NADPH
oxidase-2; MCPIP1, monocyte chemotactic protein-1-induced protein-1.
phenotype that was however associated with fully preserved
LSEC fenestrae and bioenergetics. These findings shed novel light
on the relationship between LSEC pro-inflammatory response,
fenestrae status and bioenergetics in NAFLD development
in mice.
Under physiological conditions, LSECs are characterized by
the presence of fenestrae and lack of a basement membrane.
However, liver inflammation and fibrosis are associated with loss
of fenestrae and formation of a continuous basement membrane,
the latter due to deposition of extracellular matrix in the space
of Disse (Maslak et al., 2015a). The phenomenon of LSEC
defenestration is known to contribute to various liver pathologies
(Mori et al., 1993; Steffan et al., 1995; Yamamoto et al., 1996;
Wang et al., 2005) and was also suggested to play a pivotal role in
NAFLD progression known to involve LSEC dysfunction (Miyao
et al., 2015). However, it is not clear whether LSEC inflammatory
response is linked with LSECs’ defenestration. Therefore, in the
current study we re-evaluated this relationship and demonstrated
that in the early phase of NAFLD (after 2 weeks of HFD), LSECs
displayed a mild pro-inflammatory phenotype, while pronounced
inflammatory activation was noticed at the late stage of NAFLD
(20 weeks of HFD). Importantly, LSEC inflammation was not
related to their defenestration or impaired bioenergetics.
Previously, a number of reports have demonstrated that
intralobular inflammation, hepatic fibrosis, and cirrhosis are
characterized by the presence of defenestrated LSECs (Dobbs
et al., 1994; Straub et al., 2007). Furthermore, liver recovery
in thioacetamide (TAA)-induced and in CDAA-induced murine
models of NASH were related to the reversal of LSEC
defenestration (Xie et al., 2012; Miyao et al., 2015). On the
other hand, the relation of LSEC inflammation in the process
of defenestration and its contribution in the pathophysiology
of NAFLD was not elucidated previously. Miyao et al. (2015),
using CDAA, and HFD models of NASH/NAFLD, suggested
that LSEC defenestration was observed in both of them. In a
CDAA model, LSEC defenestration preceded the appearance
of inflammation and fibrosis, although activation of Kupffer
cells and HSCs at the transcriptional level was already observed
at the stage of LSEC defenestration. On the other hand,
in an HFD model, LSEC capillarization was absent until
occurrence of intralobular inflammatory cell infiltration and
fibrosis present after 22 weeks of experimental feeding in the
work of Miyao et al. (2015). In our hands, liver inflammation
and fibrosis were virtually absent in the HFD model, in
contrast to the work of Miyao et al. (2015). However, a
significant LSEC inflammatory response was present, but was
not associated with LSEC defenestration. Accordingly, our
results extend the previous reports and suggest that LSEC
dysfunction and inflammation, as long as HSC-induced fibrosis
and LSEC basement membrane formation is maintained, are
not necessarily linked to defenestration. Moreover, our data
point to the fact, that liver steatosis without infiltrating immune
cells, HSC activation and fibrosis was related with increased
fenestrae diameter, rather than with defenestration. These
findings suggest that LSEC inflammation and defenestration
are not necessarily linked to each other; furthermore, LSEC
inflammation might be even linked with compensatory increase
in LSEC fenestrae diameter.
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FIGURE 4 | PGE2 (A), PGF2α (B), 6-keto-PGF1α (C), and PGD2 (D) production by primary LSEC isolated from C57Bl/6 mice fed AIN-93G and HFD for 2 and
20 weeks. Values are means ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from HFD feeding time-matched AIN-93G group values. AIN-93G,
AIN-93G diet fed group; HFD, high fat diet fed group.
In our work, we used two complementary methods to analyze
fenestrae in primary LSECs isolated from mice fed HFD as well
as control mice. We took advantage of SEM, as a standard
method used by many authors to study fenestrae morphology
(Braet et al., 1996a; Simon-Santamaria et al., 2010; Xie et al.,
2012) and the unique method of AFM imaging that has been
advanced for LSEC morphology probing (Braet et al., 1996c;
Zapotoczny et al., 2017b,c).
Even though, the accuracy of the fenestrae measurement
depends on the technique of biological material preparation, that
is distinct for SEM and AFM, quite surprisingly, for control mice
mean fenestrae diameter of LSEC fenestra was quite similar for
both measurements (2 vs. 20 weeks, 155 ± 42 vs. 131 ± 27 nm
for SEM and 142 ± 58 vs. 158 ± 64 nm for AFM, respectively)
suggesting that LSECs’ absolute diameter is relatively preserved
for control LSECs analyzed under experimental conditions of
SEM and AFM measurements. In contrast, porosity values were
quite different for SEM vs. AFM (2 vs. 20 weeks, 20 ± 2 vs.
10 ± 4 nm for SEM and 11 ± 3 vs. 7 ± 3 nm for AFM). On the
other hand, only SEM data showed increase in fenestrae diameter
resulted from HFD feeding at every stage of NAFLD, while the
AFM technique showed such an effect only for the late phase
of NAFLD. Both techniques identified also that LSEC porosity
did not change with the progression of NAFLD, but decreased
with age.
Altogether, our results clearly demonstrate that in an HFD-
model of NAFLD, LSEC fenestrae are preserved and have
increased diameter in HFD in comparison to AIN-93G groups.
These results might indicate that excessive fat influx to the
liver results in increased LSEC fenestrae diameter increasing
the passage of lipids and other molecules to the main place
of its metabolism, to hepatocytes possibly protecting against
lipotoxicity of other cells in the liver. A similar suggestion was
made by Fraser et al. (1980). Authors suggested a beneficial effect
of increased porosity of LSECs sieve in the development of acute
fatty liver after alcohol consumption. Accordingly, regulation of
LSEC fenestrae diameter may play an important adaptive role in
lipid transport and metabolism in NAFLD development.
The structure of LSEC fenestrae is maintained by the presence
of a sieve plate-associated cytoskeleton and FACRs, connected
to a cytoskeletal framework of microfilaments and microtubules
(Braet et al., 1995, 1996b) and cytoskeleton reorganization
(Steffan et al., 1987); an energy-demanding process, which
is involved in fenestrae dynamics (Braet et al., 1996a, 2003;
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FIGURE 5 | Morphological changes in primary LSECs isolated from C57Bl/6 mice during NAFLD progression evaluated by SEM technique. Representative
microphotographs of LSECs sive plates with fenestrae (A), histograms of LSECs fenestrae diameters (B), LSECs mean fenestrae diameter (C), and porosity (D).
Values are means ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from HFD feeding time-matched AIN-93G group values. (a) P < 0.05 AIN-93G
2 weeks vs. AIN-93G 4, 15, and 20 weeks, (b) P < 0.05 HFD 2 weeks vs. HFD 15 and 20 weeks, (c) P < 0.05 HFD 4 weeks vs. HFD 15 and 20 weeks. AIN-93G,
AIN-93G diet fed group; HFD, high fat diet fed group.
Zapotoczny et al., 2017c). In fact, it was shown that the effect
of antimycin A-derived defenestration may be related with
diminished ATP production due to inhibition of complex III of
the mitochondrial respiratory chain (Braet et al., 2003). In our
study, LSEC bioenergetics was largely preserved at early as well as
in late stages of NAFLD, suggesting that fully maintained LSEC
bioenergetics allowed to provide sufficient supplies for energetic
demand of LSECs to preserve fenestrae and modulate their size
as needed.
Altogether, our data indicate that even at late stage of
HFD-induced NAFLD progression, LSECs’ pro-inflammatory
phenotype is related with preserved LSEC bioenergetics and
maintained functional fenestrae. As a result, quite surprisingly,
we rather observed compensation, than compromise of
LSEC function.
In the current study, we showed parallel activation of pro-
inflammatory (PGE2, PGF2α) and anti-inflammatory (PGD2,
PGI2) prostanoids production in LSECs, suggesting a possible
offsetting role of LSEC-derived PGI2 and PGD2 in the
development of NAFLD. Similarly, observed activation of
MCPIP1 in LSECs, a negative regulator of inflammatory
processes in liver (Jura et al., 2012; Lin et al., 2014), most likely
was related with induction of inflammation in LSECs, since
MCPIP1 undergoes rapid and potent transcription induction
upon stimulation with pro-inflammatory molecules, such as
MCP-1, IL-1β, TNFα, and others (Skalniak et al., 2009).
These findings are in line with the notion that the adaptive
phase of LSEC inflammation is usually balanced by anti-
inflammatory mechanisms as shown in other models (Gilroy
et al., 1999; Praticò, 2008). The hepatoprotective role of PGD2
and PGI2 was previously demonstrated showing prominent
inhibition of HSC activation in ConA-induced hepatitis (Ohta
et al., 2005; Fujita et al., 2016) and reducing fructose-induced
hepatocellular steatosis (Zhang et al., 2017). Accordingly, these
adaptive changes might attenuate LSEC inflammation, modulate
function of other type of liver cells and inhibit the development
of NAFLD.
Regarding bioenergetics, although HFD transiently impaired
LSEC mitochondrial function (decrease in ATP synthesis and
diminished maximal mitochondrial respiration) as soon as after
2 weeks of HFD feeding; this effect was related to a compensatory
increase in glycolysis and maximal glycolytic capacity in LSECs.
This result indicated prominent energetic flexibility of LSECs
in order to maintain cells’ bioenergetic balance. Moreover,
quite surprisingly, LSEC bioenergetics was fully preserved at
the late stage of NAFLD, indicating LSECs’ ability to adapt
to ongoing pathological conditions as demonstrated also for
kidney mitochondria in a similar model of HFD (Ruggiero
et al., 2011). In our work, we also provide evidence that LSEC
mitochondria tend to be uncoupled. Previously, it was shown
that mitochondria isolated from HFD-fed mice liver exhibited
increased ROS production (Matsuzawa-Nagata et al., 2008),
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FIGURE 6 | Morphological changes in primary LSECs isolated from C57Bl/6 mice during NAFLD progression evaluated by AFM technique. Representative
microphotographs of LSECs sive plates with fenestrae (A), histograms of LSECs fenestrae diameters (B), LSECs mean fenestrae diameter (C), and porosity (D).
Values are means ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from HFD feeding time-matched AIN-93G group values. (a) P < 0.05 AIN-93G
2 weeks vs. AIN-93G 20 weeks, (b) P < 0.05 HFD 2 weeks vs. HFD 20 weeks. AIN-93G, AIN-93G diet fed group; HFD, high fat diet fed group.
FIGURE 7 | Basal OCR, ATP production, maximal respiration, and mitochondrial proton leak (A) and basal ECAR, glycolysis, glycolytic capacity (B) in primary LSEC
isolated from C57Bl/6 mice fed AIN-93G and HFD for 2 and 20 weeks. Values are means ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 significantly different from
HFD feeding time-matched AIN-93G group values. AIN-93G, AIN-93G diet fed group; HFD, high fat diet fed group.
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compatible with the notion that elevated influx of fatty acids
alters bioenergetic functions of liver mitochondria and results in
mitochondrial-derived oxidative stress. In the current study, we
analyzed bioenergetic response of LSECs to HFD in mice for the
first time, and demonstrated that HFD seem to increase LSECs’
mitochondrial proton leak initially, that was later normalized,
suggesting transient mitochondrial uncoupling protein-2 (UCP2)
overexpression (Evans et al., 2008) or LSEC adaptation to
increased influx of fatty acids. However further studies are needed
to evaluate role of LSEC mitochondria in lipids metabolism
in NAFLD.
In summary, we have demonstrated that in early and
in late phase of NAFLD, LSEC fenestrae are functionally
preserved despite metabolic and pro-inflammatory burden
linked to HFD and NAFLD progression. Furthermore,
we identified a number of adaptive mechanisms such as
increased production of anti-inflammatory PGI2, PGD2,
overexpression of MCPIP1 and bioenergetic adaptation. These
results indicate that LSEC fenestrae preservation in NALFD
is associated with biochemical as well as metabolic adaptive
mechanisms that may all play an important role mitigating
NAFLD progression.
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